Could a seed protein stop oral cancer? early study hints at promise

NCT ID NCT04188665

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This early-phase study looked at whether a protein from the Maackia amurensis seed (MASL) can target a receptor called podoplanin found on oral cancer and precancerous cells. Researchers measured how much of this receptor was present in tissue samples from 18 adults with suspicious mouth lesions. The goal was to see if MASL could reduce the receptor's activity and potentially slow cancer growth, but the study focused on understanding the biology rather than proving a treatment works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ORAL LICHEN PLANUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

erythroplakia head and neck squamous cell carcinoma leukoplakia lichen planus, oral oral cavity squamous cell carcinoma Squamous Cell Carcinoma of Head and Neck squamous papilloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • New Jersey Medical School

    Newark, New Jersey, 07103, United States

  • Rowan University

    Stratford, New Jersey, 08084, United States

  • Rutgers School for Dental Medicine

    Newark, New Jersey, 07103, United States

  • University Hospital

    Newark, New Jersey, 07103, United States